dc.contributor.author | Ari, E. | |
dc.contributor.author | Yildirim, M. | |
dc.contributor.author | Kucuk, H. F. | |
dc.contributor.author | Durmaz, F. | |
dc.contributor.author | Dogu, Z. | |
dc.contributor.author | Yavuz, A. | |
dc.contributor.author | Carin, M. | |
dc.date.accessioned | 2019-08-13T12:10:23Z | |
dc.date.accessioned | 2019-08-13T15:58:23Z | |
dc.date.available | 2019-08-13T12:10:23Z | |
dc.date.available | 2019-08-13T15:58:23Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 0041-1345 | |
dc.identifier.issn | 1873-2623 | |
dc.identifier.uri | https://dx.doi.org/10.1016/j.transproceed.2015.04.066 | |
dc.identifier.uri | http://hdl.handle.net/11446/2685 | |
dc.description | WOS: 000357066800022 | en_US |
dc.description | PubMed ID: 26093711 | en_US |
dc.description.abstract | Background. Pre-transplant sensitization to human leukocyte antigens (HLA) is a risk factor for graft failure. The purpose of the current single-center study was to evaluate humoral immune response to HLA antigens and the possible relationship between anti-HLA antibody titer and autoimmune disorders in renal transplant candidates. Methods. A total of 435 renal transplant candidates were analyzed; 50 sensitized patients were enrolled in this study. The HLA typing was performed by use of enzyme-linked immunoassay combined with Luminex technology. The patients were questioned for clinical evidence of hypothyroidism and systemic lupus erythematosus (SLE) and investigated for anti-nuclear antibody (ANA), anti-double-stranded DNA (anti-dsDNA), anti-thyroglobulin (anti-TG), anti thyroid permddase (anti-TPO) antibodies, and thyroid function tests. Results. Among 50 patients with positive panel reactive antibody, 24 (48%) were positive for class I and negative for class II, 12 (24%) were negative for class I and positive for class II, and 14 (28%) were positive for both classes I and II. The specificities of anti-HLA antibodies-A23, A68, A69, B27, B49, DR6, and DR8-were the most frequent. ANA and anti-dsDNA antibodies were not correlated with either clinical symptoms of SLE or anti-HLA antibody titer of renal transplant candidates. Similarly, anti-TG and anti-TPO antibodies were not correlated with clinical hypothyroidism or anti-HLA antibody titer. Conclusions. Our data have demonstrated the profile of anti-HLA antibodies in patients who were on the renal transplant waiting list in Turkey. The most frequent specificities of anti-HLA antibodies were A23, A68, A69, B27, B49, DR6, and DR8. There was no association between anti-HLA antibody titer and clinical and laboratory evidence of SLE and hypothyroidism. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | ELSEVIER SCIENCE INC | en_US |
dc.identifier.doi | 10.1016/j.transproceed.2015.04.066 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Analysis of the Humoral Immune Response to Human Leukocyte Antigens in Turkish Renal Transplant Candidates and Relationship Between Autoimmune Disorders | en_US |
dc.type | article | en_US |
dc.relation.journal | TRANSPLANTATION PROCEEDINGS | en_US |
dc.department | DBÜ | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.volume | 47 | en_US |
dc.identifier.startpage | 1326 | en_US |
dc.identifier.endpage | 1330 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.department-temp | [Ari, E. -- Yavuz, A. -- Parmaksiz, E. -- Asicioglu, E.] Kartal Res & Training Hosp, Dept Nephrol, Istanbul, Turkey -- [Yildirim, M. -- Kucuk, H. F. -- Durmaz, F. -- Dogu, Z.] Kartal Res & Training Hosp, Dept Transplantat, Istanbul, Turkey -- [Carin, M.] Bilim Univ, Dept Immunol, Istanbul, Turkey | en_US |